SARC021 MANUSCRIPT HAS BEEN PUBLISHED!

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial The SARC021 manuscript has been published …

Read more
Back to top